The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 30266310m number, and no internal action related to the complaint was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
During a clinical trial, sponsored by bwi, it was reported that an (b)(6) female patient (5.42 ft, (b)(6)) underwent a pulmonary vein isolation (pvi) ablation procedure on (b)(6) 2019 with a thermocool® smart touch® sf bi-directional navigation catheter and suffered pericarditis and heart failure.During the procedure a total of 51 radiofrequency applications were done with the stsf catheter.No device deficiencies were reported.The procedure was successfully completed without patient consequences.Post-procedure ((b)(6) 2020), the patient developed pericarditis (ae8) and heart failure (ae11).Unspecified medication was administered.Prolonged hospitalization was required.Patient was discharged on (b)(6) 2020.The principal investigator assessed the events as severe, serious, not expected, possible related to the study device (visitag surpoint epu), possible related to the study catheter, not related to the bwi non-investigational devices (e.G pump, tubing, cables, etc), and causal related to repeat procedure ((b)(6) 2020).Issues were resolved.Since intervention and prolonged hospitalization was required to prevent permanent impairment of a body function or permanent damage to a body structure, this event is being considered serious and mdr-reportable.
|